Composition: Amlodipine Besylate (5mg) and Atenolol Tablets IP(25mg)

Dosage Form: Tablets

Packaging Type: BLISTER

Packaging: 10*10



Description

VTV FORMULATIONS INDIA PVT LTD is here to offer the best range of products for your problems. Our company manufactures and supplies top-notch quality products that people most trust. VTV FORMULATIONS INDIA PVT LTD  manufactures Amlodipine Besylate (5mg) and Atenolol Tablets IP(25mg),therefore serve our customers with quality life and healthcare products. All the products made by us are GMP, WHO, and ISO-certified.

  1. Use of best raw materials for manufacturing 
  2. Adherence to quality control and quality assurance practices.
  3. Certified companies from ISO, GMP, and WHO.
  4. Air-tight and leak-proof packaging.

  5. AMLODIPINE+ATENOLOL is an anti-hypertensive medication that is used to treat hypertension (high blood pressure). Hypertension (high blood pressure) is a lifelong or chronic condition in which the blood pressure against the artery walls becomes too high. This can lead to damaged blood vessels, heart disease, stroke, kidney disease, and other problems.AMLODIPINE+ATENOLOL contains Amlodipine (a calcium channel blocker) and Atenolol (a beta-blocker). Amlodipine acts by relaxing and widening the constricted blood vessels. This ultimately reduces the heart's workload and makes the heart more efficient at pumping blood throughout the body. Atenolol works by blocking stress hormones like adrenaline and epinephrine, thereby slowing down the increased heart rate. Thus, it helps lower raised blood pressure, reducing the chances of heart attack or stroke in the future.
  6. Side Effects 

    • Nausea

    • Sleepiness

    • Ankle swelling

    • Headache 

    • Palpitations

    • Cold extremities

    • Flushing (sense of warmth in the face, ears, neck, and trunk)

    • Slow heart rate

    • Oedema (swelling) 

    • Constipation

    • Tiredness

Over Services

Subscribe

Stay ahead in healthcare with our curated pharmaceutical products Subscribe now for exclusive access to the latest innovations.

Copyright @2021.All rights reserved.